🚨 New publication!

The #LUMEN1 trial protocol is out in @journalofnucmed.bsky.social.

This is the 1st randomised trial of [¹⁷⁷Lu]Lu-DOTATATE for recurrent #meningioma, exploring SSTR2-targeted therapy + advanced imaging, profiling & AI.

🔗 www.eortc.org/bibliography/

#EORTCBrain #NeuroOncology